Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic / 전남의대학술지
Chonnam Medical Journal
;
: 1-7, 2015.
Article
in English
| WPRIM
| ID: wpr-133656
ABSTRACT
Although the introduction of stem cell transplantation and novel agents has improved survival, multiple myeloma (MM) is still difficult to cure. Alternative approaches are clearly needed to prolong the survival of patients with MM. Dendritic cell (DC) therapy is a very promising tool immunologically in MM. We developed a method to generate potent DCs with increased Th1 polarization and migration ability for inducing strong myeloma-specific cytotoxic T lymphocytes. In this review, we discuss how the efficacy of cancer immunotherapy using DCs can be improved in MM.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Dendritic Cells
/
T-Lymphocytes, Cytotoxic
/
Stem Cell Transplantation
/
Immunotherapy
/
Multiple Myeloma
Limits:
Humans
Language:
English
Journal:
Chonnam Medical Journal
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS